Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter and full-year 2025.

By the time cancer symptoms appear, the disease has already been developing for years, often leaving subtle clues in routine ...

The search for effective and accessible therapies for diabetes continues to draw attention to medicinal plants with a long ...

Founded by IISc scientist Manjiri Bakre, OncoStem Diagnostics has developed CanAssist Breast (CAB), an AI-powered test to identify which early-stage breast cancer patients need chemotherapy and who ...

Derek Huang spent three years and $140 a month stacking supplements he was sure were protecting his health. Then his bloodwork told a different story — and the hardest part wasn't the numbers. It was ...

As the planet warms, common medications such as GLP-1s and diuretics can turn a heatwave into a medical emergency, yet many physicians feel unequipped to manage the risk.

An Italian toddler has tragically died after receiving a 'frostbitten' heart in a transplant, the family's lawyer has said.

Chugai Pharma introduces “Elevidys” as Japan’s first regenerative medical product for Duchenne muscular dystrophy: Tokyo Monday, February 23, 2026, 11:00 Hrs [IST] Chugai Ph ...